9+ hour, 17+ min ago  (1273+ words) BBN Times Sir Pascal Soriot: Veterinary Scientist, Pharmaceutical Transformer, and Executive Director and CEO of Astra Zeneca Sir Pascal Soriot is one of the most consequential pharmaceutical executives in history. He is a French-born Australian businessman who took over a…...

1+ hour, 30+ min ago  (685+ words) Disc Medicine NASDAQ: IRON Chief Executive Officer John Quisel said patient demand for the company's bitopertin program in erythropoietic protoporphyria, or EPP, remains strong after the company enrolled 183 patients in the APOLLO confirmatory study, above its original target of 150. Quisel…...

2+ week, 5+ hour ago  (566+ words) Evaxion Biotech A/S Adr ((EVAX)) has held its Q1 earnings call. Read on for the main highlights of the call. Evaxion Biotech's latest earnings call struck a notably upbeat tone, driven by strong scientific momentum across its AI-Immunology platform and…...

1+ week, 17+ hour ago  (396+ words) Detailed price information for Fibrobiologics Inc (FBLG-Q) from The Globe and Mail including charting and trades. Fibro Biologics Files Patent Application for Oral Administration of Fibroblast Therapeutics HOUSTON, May 18, 2026 (GLOBE NEWSWIRE) -- Fibro Biologics, Inc. (Nasdaq: FBLG) ("Fibro Biologics"), a clinical-stage…...

2+ week, 12+ hour ago  (497+ words) CSL now expects weaker full-year revenue and profit as plasma, China pricing, and Vifor pressures weigh on performance. Oops, something went wrong CSL Plunges 22% After Cutting Outlook And Flagging $5 Billion Impairments This article first appeared on Guru Focus. CSL Ltd....

3+ week, 3+ day ago  (152+ words) The latest announcement is out from AC Immune SA ( (ACIU) ). On April 30, 2026, AC Immune SA reported that it had dosed the first patients in Cohort AD4 of its ongoing Phase 1b/2 ABATE trial of ACI-24, an anti-amyloid beta active immunotherapy for prodromal…...

2+ week, 3+ day ago  (740+ words) Galapagos NV ((GLPG)) has held its Q1 earnings call. Read on for the main highlights of the call. Galapagos NV's latest earnings call painted a cautiously optimistic picture as the biotech pivots through a major strategic overhaul. Management highlighted the transformative…...

3+ week, 3+ day ago  (242+ words) An announcement from Evofem Biosciences ( (EVFM) ) is now available. On April 24, 2026, Evofem Biosciences, Inc. entered into an exclusive five-year agreement with Clovis Davis Pharmaceuticals, LLC to distribute, promote, market, and sell Solosec (secnidazole) 2 g oral granules in sub-Saharan Africa. Local…...

2+ week, 11+ hour ago  (597+ words) Company to initiate third planned cohort at higher dose level, including patients with myelodysplastic syndrome and myelofibrosis SOUTH SAN FRANCIS. .. CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial Company to initiate third planned cohort at higher dose…...

2+ week, 15+ hour ago  (465+ words) Detailed price information for Adia Nutrition Inc (ADIA) from The Globe and Mail including charting and trades. ADIA Nutrition Announces IRB Approval of All Four Clinical Studies and Registration of Kidney Health Study on Clinical Trials. gov Winter Park Autism…...